Werbung
Werbung

TENX

TENX logo

Tenax Therapeutics, Inc.

13.28
USD
Gesponsert
+0.16
+1.18%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

13.28

0.00
0.00%

TENX Ergebnisberichte

Positives Überraschungsverhältnis

TENX übertreffen die 20 der letzten 37Schätzungen.

54%

Nächster Bericht

Datum des nächsten Berichts
23. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.42
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+5.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
+133.33%

Tenax Therapeutics, Inc. earnings per share and revenue

On 12. Nov. 2025, TENX reported earnings of -0.40 USD per share (EPS) for Q3 25, missing the estimate of -0.31 USD, resulting in a -25.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.42 USD, with revenue projected to reach -- USD, implying an increase of 5.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Tenax Therapeutics, Inc. reported EPS of -$0.40, missing estimates by -25.47%, and revenue of $0.00, 0% as expectations.
The stock price moved down -4.29%, changed from $6.99 before the earnings release to $6.69 the day after.
The next earning report is scheduled for 23. März 2026.
Based on 7 analysts, Tenax Therapeutics, Inc. is expected to report EPS of -$0.42 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung